CD4+ T cells from lupus-prone mice avoid antigen-specific tolerance induction in vivo

被引:26
作者
Bouzahzah, F
Jung, S
Craft, J
机构
[1] Yale Univ, Sch Med, Dept Med, Rheumatol Sect, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
关键词
D O I
10.4049/jimmunol.170.2.741
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activated T cells in spontaneous lupus presumably bypass normal tolerance mechanisms in the periphery, since thymic tolerance appears intact. To determine whether such T cells indeed avoid in vivo peripheral tolerance mechanisms, we assessed their activation and recall responses after in vivo Ag stimulation in the absence of exogenously supplied costimulatory signals. Naive CD4(+) AND (transgenic mice bearing rearranged TCR specific for pigeon cytochrome c, peptides 88-104) TCR-transgenic T cells, specific for pigeon cytochrome c, from lupus-prone Fas-intact MRL/Mp+(Fas-Ipr) and from H-2(k)-matched control CBA/CaJ and B10BR mice (MRL.AND, CBA.AND, and B10.AND, respectively) were adoptively transferred into (MRL x CBA)F-1 or (MRL x B10)F-1 recipients transgenically expressing membrane-bound pigeon cytochrome c as a self-Ag. MRL.AND and control CBA.AND and B10.AND-transgenic T cells were activated and divided after transfer, indicating encounter with their cognate Ag; however, T cells from CBA.AND and B10.AND mice were impaired in their ability to proliferate and produce IL-2 after challenge with pigeon cytochrome c in ex vivo recall assays, a typical phenotype of anergized cells. By contrast, MRL.AND T cells proliferated more, and a significantly higher percentage of such cells produced IL-2, compared with control T cells. This observation that MRL T cells avoided anergy induction in vivo was confirmed in an in vitro system where the cells were stimulated with an anti-CD3 in the absence of a costimulatory signal. These experiments provide direct evidence that CD4(+) T cells from Fas-intact lupus-prone MRL mice are more resistant than nonautoimmune control cells to anergy induction. Anergy avoidance in the periphery might contribute to the characteristic finding in lupus of inappropriate T cell activation in response to ubiquitous self-Ags.
引用
收藏
页码:741 / 748
页数:8
相关论文
共 69 条
[1]   CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells [J].
Adler, AJ ;
Marsh, DW ;
Yochum, GS ;
Guzzo, JL ;
Nigam, A ;
Nelson, WG ;
Pardoll, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) :1555-1564
[2]  
Alleva DG, 1997, J IMMUNOL, V159, P5610
[3]   Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b [J].
Bachmaier, K ;
Krawczyk, C ;
Kozieradzki, I ;
Kong, YY ;
Sasaki, T ;
Oliveira-dos-Santos, A ;
Mariathasan, S ;
Bouchard, D ;
Wakeham, A ;
Itie, A ;
Le, J ;
Ohashi, PS ;
Sarosi, I ;
Nishina, H ;
Lipkowitz, S ;
Penninger, JM .
NATURE, 2000, 403 (6766) :211-216
[4]   CLONAL ANERGY TO STAPHYLOCOCCAL ENTEROTOXIN-B IN-VIVO - SELECTIVE EFFECTS ON T-CELL SUBSETS AND LYMPHOKINES [J].
BASCHIERI, S ;
LEES, RK ;
LUSSOW, AR ;
MACDONALD, HR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (10) :2661-2666
[5]   Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus [J].
Blanco, P ;
Palucka, AK ;
Gill, M ;
Pascual, V ;
Banchereau, J .
SCIENCE, 2001, 294 (5546) :1540-1543
[6]  
Brundula V, 1999, ARTHRITIS RHEUM-US, V42, P1908, DOI 10.1002/1529-0131(199909)42:9<1908::AID-ANR17>3.0.CO
[7]  
2-7
[8]   The resistance of activated T-cells from SLE patients to apoptosis induced by human thymic stromal cells [J].
Budagyan, VM ;
Bulanova, EG ;
Sharova, NI ;
Nikonova, MF ;
Stanislav, ML ;
Yarylin, AA .
IMMUNOLOGY LETTERS, 1998, 60 (01) :1-5
[9]   Fas modulation of apoptosis during negative selection of thymocytes [J].
Castro, JE ;
Listman, JA ;
Jacobson, BA ;
Wang, YS ;
Lopez, PA ;
Ju, ST ;
Finn, PW ;
Perkins, DL .
IMMUNITY, 1996, 5 (06) :617-627
[10]   Immobilized anti-CD3 mAb induces anergy in murine naive and memory CD4(+) T cells in vitro [J].
Chai, JG ;
Lechler, RI .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (07) :935-944